CD8, like CD4, and cytotoxic molecules (including TIA and granzyme) are readily detectable via IHC staining of tissue and, when expressed on the phenotypically abnormal T-cell population, can help distinguish specific CTCL subtypes. The gene discussed is CD8A; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.